Setbacks have resulted in delays across all three of Pfizer Inc's (NYSE: PFE) gene therapy programs, the Company revealed in its Q3 conference ...
https://www.google.com/url?rct=j&sa=t&url=https://www.benzinga.com/general/biotech/21/11/23833041/pfizer-unveils-delays-across-its-gene-therapy-programs&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNHkex354bT7XWJF6lTQYJfLfEk58Q
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.